top of page

Biotech's movers for the week of May 18th and a preview of the week ahead

60 minutes ago
1 min read

Oncology names moved ahead of next week's ASCO Annual Meeting, and Immunovant traded up on an update for its FcRn, IMVT-1402.

https://vimeo.com/1195076570

Recent Posts

Cartesian Therapeutics is working on CAR-T for autoimmune conditions, but with the unique angle that it is using a mRNA approach rather than DNA

Cartesian Therapeutics is working on CAR-T for autoimmune conditions, but with the unique angle that it is using a mRNA approach rather than DNA

Sutro Biopharma is developing next generation antibody-drug conjugates, including dual payload ADCs. CEO Jane Chung walks us through their programs

Sutro Biopharma is developing next generation antibody-drug conjugates, including dual payload ADCs. CEO Jane Chung walks us through their programs

Kyverna became the first company this month to initiate a BLA for CAR-T to treat an autoimmune condition. CEO Warner Biddle describes Stiff Person Syndrome and what it means as PoC

Kyverna became the first company this month to initiate a BLA for CAR-T to treat an autoimmune condition. CEO Warner Biddle describes Stiff Person Syndrome and what it means as PoC

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

bottom of page